XML 82 R72.htm IDEA: XBRL DOCUMENT
v3.21.2

INVESTMENTS – RELATED PARTIES (Details Narrative) - USD ($) |  |  |  | 6 Months Ended | 12 Months Ended |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Jun. 15, 2021 | Mar. 12, 2021 | Feb. 25, 2021 | Jun. 30, 2021 | Dec. 31, 2020 | Aug. 12, 2021 | Jun. 11, 2021 | Jun. 04, 2021 | Apr. 13, 2021 | Mar. 09, 2021
IPO [Member] |  |  |  |  |  |  |  |  |  |
Condensed Cash Flow Statements, Captions [Line Items] |  |  |  |  |  |  |  |  |  |
Share price | $ 5.00 |  |  |  |  |  |  |  |  |
Shares, Issued | 2,000,000 |  |  |  |  |  |  |  |  |
Aggregate public offering | $ 10,000,000 |  |  |  |  |  |  |  |  |
Unrealized gains on equity securities - related party |  |  |  |  |  |  |  |  |  |
Condensed Cash Flow Statements, Captions [Line Items] |  |  |  |  |  |  |  |  |  |
Convertible promissory note aggregate principal amount |  |  |  | $ 50,000 |  |  |  |  |  |
Avalanche International Corp And Alzamend [Member] |  |  |  |  |  |  |  |  |  |
Condensed Cash Flow Statements, Captions [Line Items] |  |  |  |  |  |  |  |  |  |
Unrealized gain (loss) on its investment |  |  |  |  | $ 860,000 |  |  |  |  |
Loan Agreement [Member] |  |  |  |  |  |  |  |  |  |
Condensed Cash Flow Statements, Captions [Line Items] |  |  |  |  |  |  |  |  |  |
Principal amount |  |  |  |  |  |  |  | $ 20,000,000 | $ 15,000,000 |
Recognized a loss on issuance of warrants |  |  |  |  |  |  |  |  |  |
Condensed Cash Flow Statements, Captions [Line Items] |  |  |  |  |  |  |  |  |  |
Share price |  |  |  |  |  |  | $ 2.99 |  |  | $ 1.50
Avalanche International Corp. [Member] | Common Stock [Member] |  |  |  |  |  |  |  |  |  |
Condensed Cash Flow Statements, Captions [Line Items] |  |  |  |  |  |  |  |  |  |
Unrealized gain (loss) on its investment |  |  |  | $ 30,000 |  |  |  |  |  |
Closing price of stock |  |  |  | $ 0.45 | $ 0.50 |  |  |  |  |
Avalanche International Corp. [Member] | Services Transferred Over Time [Member] |  |  |  |  |  |  |  |  |  |
Condensed Cash Flow Statements, Captions [Line Items] |  |  |  |  |  |  |  |  |  |
Convertible promissory note aggregate principal amount |  |  |  | $ 1,360,000 |  |  |  |  |  |
Avalanche International Corp. [Member] | Philou Ventures L L C [Member] |  |  |  |  |  |  |  |  |  |
Condensed Cash Flow Statements, Captions [Line Items] |  |  |  |  |  |  |  |  |  |
Convertible promissory note aggregate principal amount |  |  |  | $ 1,500,000.0 |  |  |  |  |  |
Interest rate |  |  |  | 12.00% |  |  |  |  |  |
Number of warrants purchased |  |  |  | 3,010,000 |  |  |  |  |  |
Conversion price (in dollars per share) |  |  |  | $ 0.50 |  |  |  |  |  |
Warrant term |  |  |  | 5 years |  |  |  |  |  |
Avalanche International Corp. [Member] | Philou Ventures L L C [Member] | Ownership [Member] |  |  |  |  |  |  |  |  |  |
Condensed Cash Flow Statements, Captions [Line Items] |  |  |  |  |  |  |  |  |  |
Ownership percentage |  |  |  | 1800.00% |  |  |  |  |  |
Unrealized gains on equity securities - related party |  |  |  |  |  |  |  |  |  |
Condensed Cash Flow Statements, Captions [Line Items] |  |  |  |  |  |  |  |  |  |
Interest rate |  |  |  | 8.00% |  |  |  |  |  |
Number of warrants purchased |  |  |  | 16,667 |  |  |  |  |  |
Warrant term |  |  |  | 5 years |  |  |  |  |  |
Unrealized gain (loss) on its investment |  |  |  | $ 860,000 |  |  |  |  |  |
Short-term advance |  |  |  | 750,000 |  |  |  |  |  |
Unrealized gains on equity securities - related party | Recognized a loss on issuance of warrants |  |  |  |  |  |  |  |  |  |
Condensed Cash Flow Statements, Captions [Line Items] |  |  |  |  |  |  |  |  |  |
Convertible promissory note aggregate principal amount |  |  |  |  |  |  |  |  |  | $ 800,000
Unrealized gain (loss) on its investment |  | $ 31,700,000 |  | $ 3,170,000 |  |  |  |  |  |
Investment in common stock and warrants |  | $ 10.0 |  |  |  |  |  |  |  |
Description of reamaining funded amount |  | The remaining $6.0 million will be funded upon Alzamend achieving certain milestones related to the U.S. Food and Drug Administration approval of Alzamend’s Investigational New Drug application and Phase 1a human clinical trials for Alzamend’s lithium based ionic cocrystal therapy, known as AL001 |  |  |  |  |  |  |  |
Description of agreement |  | Alzamend has agreed to sell up to 6,666,667 shares of its common stock to DP Lending for $10.0 million, or $1.50 per share, and issue to DP Lending warrants to acquire 3,333,334 shares of Alzamend common stock with an exercise price of $3.00 per share |  |  |  |  |  |  |  |
Fair value of common stock |  |  |  | $ 8.74 |  | $ 3.83 |  |  |  | $ 8.74
Ault And Company Inc [Member] |  |  |  |  |  |  |  |  |  |
Condensed Cash Flow Statements, Captions [Line Items] |  |  |  |  |  |  |  |  |  |
Interest rate |  |  | 800.00% |  |  |  |  |  |  |
Principal amount |  |  | $ 250,000,000,000 |  |  |  |  |  |  |
Maturity date |  |  | Feb. 25, 2022 |  |  |  |  |  |  |

X
- References No definition available. + Details
Name: | dpw_ClosingPriceOfStock1
Namespace Prefix: | dpw_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The information of description of agreement. + References No definition available. + Details
Name: | dpw_DescriptionOfAgreement
Namespace Prefix: | dpw_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The information of description of reamaining funded amount. + References No definition available. + Details
Name: | dpw_DescriptionOfReamainingFundedAmount
Namespace Prefix: | dpw_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | dpw_FairValueOfCommonStock1
Namespace Prefix: | dpw_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- References No definition available. + Details
Name: | dpw_FinancingReceivableConversionPrice
Namespace Prefix: | dpw_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition It represents as a financing receivable face amount. + References No definition available. + Details
Name: | dpw_FinancingReceivableFaceAmount
Namespace Prefix: | dpw_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition The amount of investment in common stock and warrants. + References No definition available. + Details
Name: | dpw_InvestmentInCommonStockAndWarrants
Namespace Prefix: | dpw_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | srt_CondensedCashFlowStatementsCaptionsLineItems
Namespace Prefix: | srt_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face (par) amount of debt instrument at time of issuance. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 55 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 55 -Paragraph 69C -URI http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612 Reference 6: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 55 -Paragraph 69B -URI http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612 + Details
Name: | us-gaap_DebtInstrumentFaceAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Contractual interest rate for funds borrowed, under the debt agreement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(1)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_DebtInstrumentInterestRateStatedPercentage
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(2)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 20 -Section 50 -Paragraph 1B -Subparagraph (d) -URI http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_DebtInstrumentMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | duration

X
- Definition The parent entity's interest in net assets of the subsidiary, expressed as a percentage. + References No definition available. + Details
Name: | us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The excess of the (1) fair value of consideration transferred to the holders of a security in excess of (2) the carrying amount of the security reported on the registrant's balance sheet, which will be deducted from net earnings to derive net earnings available to common shareholders. This amount is generally an adjustment considered in the computation of earnings per share. + References No definition available. + Details
Name: | us-gaap_RedemptionPremium
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644 + Details
Name: | us-gaap_SharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Per share or per unit amount of equity securities issued. + References No definition available. + Details
Name: | us-gaap_SharesIssuedPricePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(4)) -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03(5)) -URI http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03(a)(1)(g)) -URI http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(2)) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_ShortTermInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of unrealized gain (loss) on investment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585 + Details
Name: | us-gaap_UnrealizedGainLossOnInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -URI http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258 + Details
Name: | us-gaap_WarrantsAndRightsOutstandingTerm
Namespace Prefix: | us-gaap_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=dpw_AlzamendMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=dpw_AvalancheInternationalCorpAndAlzamendMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=dpw_LoanAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=dpw_SecuritiesPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | dei_LegalEntityAxis=dpw_AvalancheInternationalCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=dpw_ConvertiblePromissoryNoteTenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dpw_AvalancheInternationalCorpMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_ConsolidatedEntitiesAxis=dpw_PhilouVenturesLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_OwnershipAxis=dpw_OwnershipMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dpw_AlzamendMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=dpw_AultAndCompanyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |